437 related articles for article (PubMed ID: 37373023)
21. Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.
Cui Q; Li X; Zhu H
Mol Med Rep; 2016 Feb; 13(2):1381-8. PubMed ID: 26648392
[TBL] [Abstract][Full Text] [Related]
22. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
Rekha KR; Inmozhi Sivakamasundari R
Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
[TBL] [Abstract][Full Text] [Related]
24. Novel anti-apoptotic L-DOPA precursors SuperDopa and SuperDopamide as potential neuroprotective agents for halting/delaying progression of Parkinson's disease.
Wiesen T; Atlas D
Cell Death Dis; 2022 Mar; 13(3):227. PubMed ID: 35277478
[TBL] [Abstract][Full Text] [Related]
25. The neuroprotective effects of hydro-alcoholic extract of olive (Olea europaea L.) leaf on rotenone-induced Parkinson's disease in rat.
Sarbishegi M; Charkhat Gorgich EA; Khajavi O; Komeili G; Salimi S
Metab Brain Dis; 2018 Feb; 33(1):79-88. PubMed ID: 29039078
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D3 actions on astrocyte cells: A target for therapeutic strategy in Parkinson's disease?
de Siqueira EA; Magalhães EP; de Menezes RRPPB; Sampaio TL; Lima DB; da Silva Martins C; Neves KRT; de Castro Brito GA; Martins AMC; de Barros Viana GS
Neurosci Lett; 2023 Jan; 793():136997. PubMed ID: 36470505
[TBL] [Abstract][Full Text] [Related]
29. Fenofibrate promotes neuroprotection in a model of rotenone-induced Parkinson's disease.
Barbiero JK; Ramos DC; Boschen S; Bassani T; Da Cunha C; Vital MABF
Behav Pharmacol; 2022 Dec; 33(8):513-526. PubMed ID: 36094044
[TBL] [Abstract][Full Text] [Related]
30. Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation.
Ozbey G; Nemutlu-Samur D; Parlak H; Yildirim S; Aslan M; Tanriover G; Agar A
Pharmacol Rep; 2020 Oct; 72(5):1397-1406. PubMed ID: 32207092
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson's disease.
El-Sayed EK; Ahmed A; Morsy EE; Nofal S
Hum Exp Toxicol; 2019 Feb; 38(2):173-184. PubMed ID: 30001633
[TBL] [Abstract][Full Text] [Related]
32. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk.
Shirgadwar SM; Kumar R; Preeti K; Khatri DK; Singh SB
J Alzheimers Dis; 2023; 94(s1):S109-S124. PubMed ID: 36463449
[TBL] [Abstract][Full Text] [Related]
34. Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and α-synuclein expressions in rats.
Ishola IO; Awogbindin IO; Olubodun-Obadun TG; Olajiga AE; Adeyemi OO
Neurotoxicology; 2023 May; 96():37-52. PubMed ID: 36965781
[TBL] [Abstract][Full Text] [Related]
35. The role of stinging nettle (Urtica dioica L.) in the management of rotenone-induced Parkinson's disease in rats.
Albadawi E; El-Tokhy A; Albadrani M; Adel M; El-Gamal R; Zaarina W; El-Agawy MSE; Elsayed HRH
Tissue Cell; 2024 Apr; 87():102328. PubMed ID: 38387425
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy.
Lin TK; Chen SD; Chuang YC; Lin HY; Huang CR; Chuang JH; Wang PW; Huang ST; Tiao MM; Chen JB; Liou CW
Int J Mol Sci; 2014 Jan; 15(1):1625-46. PubMed ID: 24451142
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
38. Omarigliptin attenuates rotenone-induced Parkinson's disease in rats: Possible role of oxidative stress, endoplasmic reticulum stress and immune modulation.
Michel HE; Tadros MM; Hendy MS; Mowaka S; Ayoub BM
Food Chem Toxicol; 2022 Jun; 164():113015. PubMed ID: 35439590
[TBL] [Abstract][Full Text] [Related]
39. Nanostructure lipid carriers enhance alpha-mangostin neuroprotective efficacy in mice with rotenone-induced neurodegeneration.
Sakamula R; Yata T; Thong-Asa W
Metab Brain Dis; 2022 Jun; 37(5):1465-1476. PubMed ID: 35353275
[TBL] [Abstract][Full Text] [Related]
40. Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 Secretion.
Sharma N; Soni R; Sharma M; Chatterjee S; Parihar N; Mukarram M; Kale R; Sayyed AA; Behera SK; Khairnar A
Mol Neurobiol; 2022 Nov; 59(11):6834-6856. PubMed ID: 36048341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
